Long-standing client Jagex, one of the UK’s largest video game developers and publishers, on its sale to The Carlyle Group. The transaction positions Jagex for continued growth in the global gaming market, building upon its existing 300 million players accounts and $1bn RuneScape franchise.
Global pharmaceutical company WuXi AppTec on its acquisition of OXGENE, a pioneering United Kingdom-based contract research and development (R&D) organisation that designs and develops scalable gene therapy technologies.
Glenmark Pharma on the sale of its portfolio of CNS products in Poland to Neuraxpharm
Glenmark Pharma on its divestment of its CNS business in Poland including its portfolio of generics and branded generics products and the transfer of its commercial team in Poland to private equity backed Neuraxpharm, a specialty pharmaceutical company focused on the treatment of CNS disorders.